Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.

①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.

cls.cnNov 1 08:59 ET

Shandong Xinhua Pharmaceutical's Attributable Profit Falls 12% in January-September

MT NewswiresOct 30 00:21 ET

zheshang: Continuous realization of technological innovation upgrade driving the continuous improvement of performance expectations for innovative drugs and industry chain.

The commercialization period of innovative drugs in the industry chain, driven purely by incremental value, is entering the phase of realization. The scarce incremental prosperity of the pharmaceutical sector continues to rise, with increasing international competitiveness, and there is still room for upward valuation.

Zhitong FinanceOct 29 22:28 ET

Xinhua Pharmaceuticals: Report for the third quarter of 2024

SZSIOct 29 12:00 ET · Announcements

Shandong Xinhua Pharmaceutical (000756.SZ): Achieved revenue of 6.734 billion yuan in the first three quarters, a year-on-year increase of 3.64%.

Grain News October 29th | Shandong Xinhua Pharmaceutical (000756.SZ) announced its third quarter report for 2024, achieving revenue of 6.734 billion yuan in the first three quarters, a year-on-year increase of 3.64%; net income attributable to shareholders of the listed company was 0.344 billion yuan, a year-on-year decrease of 12.22%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.321 billion yuan, a year-on-year decrease of 11.39%; basic earnings per share was 0.50 yuan.

Gelonghui FinanceOct 29 06:10 ET

Shandong Xinhua Pharmaceutical (00719) released the performance for the first three quarters, with a net income of 0.344 billion yuan.

shandong xinhua pharmaceutical (00719) released its performance for the nine months ended September 30, 2024, with the group achieving...

Zhitong FinanceOct 29 04:34 ET